Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Medications for Smoking Cessation Market Report, History and Forecast 2015-2026, Breakdown Data by Companies, Key Regions, Types and Application

Request for Sample of this report
Buy now

1 Market Overview of Medications for Smoking Cessation

  • 1.1 Medications for Smoking Cessation Market Overview
    • 1.1.1 Medications for Smoking Cessation Product Scope
    • 1.1.2 Market Status and Outlook
  • 1.2 Global Medications for Smoking Cessation Market Size Overview by Region 2015 VS 2020 VS 2026
  • 1.3 Global Medications for Smoking Cessation Market Size by Region (2015-2026)
  • 1.4 Global Medications for Smoking Cessation Historic Market Size by Region (2015-2020)
  • 1.5 Global Medications for Smoking Cessation Market Size Forecast by Region (2021-2026)
  • 1.6 Key Regions, Medications for Smoking Cessation Market Size YoY Growth (2015-2026)
    • 1.6.1 North America Medications for Smoking Cessation Market Size YoY Growth (2015-2026)
    • 1.6.2 Europe Medications for Smoking Cessation Market Size YoY Growth (2015-2026)
    • 1.6.3 Asia-Pacific Medications for Smoking Cessation Market Size YoY Growth (2015-2026)
    • 1.6.4 Latin America Medications for Smoking Cessation Market Size YoY Growth (2015-2026)
    • 1.6.5 Middle East & Africa Medications for Smoking Cessation Market Size YoY Growth (2015-2026)

2 Medications for Smoking Cessation Market Overview by Type

  • 2.1 Global Medications for Smoking Cessation Market Size by Type: 2015 VS 2020 VS 2026
  • 2.2 Global Medications for Smoking Cessation Historic Market Size by Type (2015-2020)
  • 2.3 Global Medications for Smoking Cessation Forecasted Market Size by Type (2021-2026)
  • 2.4 Non Nicotine Drugs
  • 2.5 Nicotine Replacement Therapy (NRT)

3 Medications for Smoking Cessation Market Overview by Application

  • 3.1 Global Medications for Smoking Cessation Market Size by Application: 2015 VS 2020 VS 2026
  • 3.2 Global Medications for Smoking Cessation Historic Market Size by Application (2015-2020)
  • 3.3 Global Medications for Smoking Cessation Forecasted Market Size by Application (2021-2026)
  • 3.4 Hospital Pharmacies
  • 3.5 Retailer Pharmacies
  • 3.6 Online Pharmacies

4 Global Medications for Smoking Cessation Competition Analysis by Players

  • 4.1 Global Medications for Smoking Cessation Market Size by Players (2015-2020)
  • 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medications for Smoking Cessation as of 2019)
  • 4.3 Date of Key Manufacturers Enter into Medications for Smoking Cessation Market
  • 4.4 Global Top Players Medications for Smoking Cessation Headquarters and Area Served
  • 4.5 Key Players Medications for Smoking Cessation Product Solution and Service
  • 4.6 Competitive Status
    • 4.6.1 Medications for Smoking Cessation Market Concentration Rate
    • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles and Key Data

  • 5.1 Nicotek
    • 5.1.1 Nicotek Profile
    • 5.1.2 Nicotek Main Business
    • 5.1.3 Nicotek Medications for Smoking Cessation Products, Services and Solutions
    • 5.1.4 Nicotek Medications for Smoking Cessation Revenue (US$ Million) & (2015-2020)
    • 5.1.5 Nicotek Recent Developments
  • 5.2 Cipla
    • 5.2.1 Cipla Profile
    • 5.2.2 Cipla Main Business
    • 5.2.3 Cipla Medications for Smoking Cessation Products, Services and Solutions
    • 5.2.4 Cipla Medications for Smoking Cessation Revenue (US$ Million) & (2015-2020)
    • 5.2.5 Cipla Recent Developments
  • 5.3 GlaxoSmithKline
    • 5.5.1 GlaxoSmithKline Profile
    • 5.3.2 GlaxoSmithKline Main Business
    • 5.3.3 GlaxoSmithKline Medications for Smoking Cessation Products, Services and Solutions
    • 5.3.4 GlaxoSmithKline Medications for Smoking Cessation Revenue (US$ Million) & (2015-2020)
    • 5.3.5 Dr Reddy's Laboratories Recent Developments
  • 5.4 Dr Reddy's Laboratories
    • 5.4.1 Dr Reddy's Laboratories Profile
    • 5.4.2 Dr Reddy's Laboratories Main Business
    • 5.4.3 Dr Reddy's Laboratories Medications for Smoking Cessation Products, Services and Solutions
    • 5.4.4 Dr Reddy's Laboratories Medications for Smoking Cessation Revenue (US$ Million) & (2015-2020)
    • 5.4.5 Dr Reddy's Laboratories Recent Developments
  • 5.5 Johnson & Johnson
    • 5.5.1 Johnson & Johnson Profile
    • 5.5.2 Johnson & Johnson Main Business
    • 5.5.3 Johnson & Johnson Medications for Smoking Cessation Products, Services and Solutions
    • 5.5.4 Johnson & Johnson Medications for Smoking Cessation Revenue (US$ Million) & (2015-2020)
    • 5.5.5 Johnson & Johnson Recent Developments
  • 5.6 Fontem Ventures
    • 5.6.1 Fontem Ventures Profile
    • 5.6.2 Fontem Ventures Main Business
    • 5.6.3 Fontem Ventures Medications for Smoking Cessation Products, Services and Solutions
    • 5.6.4 Fontem Ventures Medications for Smoking Cessation Revenue (US$ Million) & (2015-2020)
    • 5.6.5 Fontem Ventures Recent Developments
  • 5.7 Pfizer
    • 5.7.1 Pfizer Profile
    • 5.7.2 Pfizer Main Business
    • 5.7.3 Pfizer Medications for Smoking Cessation Products, Services and Solutions
    • 5.7.4 Pfizer Medications for Smoking Cessation Revenue (US$ Million) & (2015-2020)
    • 5.7.5 Pfizer Recent Developments
  • 5.8 NovartisNjoy Inc
    • 5.8.1 NovartisNjoy Inc Profile
    • 5.8.2 NovartisNjoy Inc Main Business
    • 5.8.3 NovartisNjoy Inc Medications for Smoking Cessation Products, Services and Solutions
    • 5.8.4 NovartisNjoy Inc Medications for Smoking Cessation Revenue (US$ Million) & (2015-2020)
    • 5.8.5 NovartisNjoy Inc Recent Developments
  • 5.9 Perrigo and Reynolds American Inc.
    • 5.9.1 Perrigo and Reynolds American Inc. Profile
    • 5.9.2 Perrigo and Reynolds American Inc. Main Business
    • 5.9.3 Perrigo and Reynolds American Inc. Medications for Smoking Cessation Products, Services and Solutions
    • 5.9.4 Perrigo and Reynolds American Inc. Medications for Smoking Cessation Revenue (US$ Million) & (2015-2020)
    • 5.9.5 Perrigo and Reynolds American Inc. Recent Developments

6 North America

  • 6.1 North America Medications for Smoking Cessation Market Size by Country
  • 6.2 United States
  • 6.3 Canada

7 Europe

  • 7.1 Europe Medications for Smoking Cessation Market Size by Country
  • 7.2 Germany
  • 7.3 France
  • 7.4 U.K.
  • 7.5 Italy
  • 7.6 Russia
  • 7.7 Nordic
  • 7.8 Rest of Europe

8 Asia-Pacific

  • 8.1 Asia-Pacific Medications for Smoking Cessation Market Size by Region
  • 8.2 China
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia
  • 8.6 India
  • 8.7 Australia
  • 8.8 Rest of Asia-Pacific

9 Latin America

  • 9.1 Latin America Medications for Smoking Cessation Market Size by Country
  • 9.2 Mexico
  • 9.3 Brazil
  • 9.4 Rest of Latin America

10 Middle East & Africa

  • 10.1 Middle East & Africa Medications for Smoking Cessation Market Size by Country
  • 10.2 Turkey
  • 10.3 Saudi Arabia
  • 10.4 UAE
  • 10.5 Rest of Middle East & Africa

11 Medications for Smoking Cessation Market Dynamics

  • 11.1 Industry Trends
  • 11.2 Market Drivers
  • 11.3 Market Challenges
  • 11.4 Market Restraints

12 Research Finding /Conclusion

    13 Methodology and Data Source

    • 13.1 Methodology/Research Approach
      • 13.1.1 Research Programs/Design
      • 13.1.2 Market Size Estimation
      • 13.1.3 Market Breakdown and Data Triangulation
    • 13.2 Data Source
      • 13.2.1 Secondary Sources
      • 13.2.2 Primary Sources
    • 13.3 Disclaimer

    Smoking cessation drugs are de-addiction drugs for smoking. The alkaloid compound called nicotine causes addictive dependency on cigarettes and other smoking products. Smoking cessation results in withdrawal symptoms such as anxiety, strong cravings, depressing mood, insomnia and mood alterations.

    Market Analysis and Insights: Global Medications for Smoking Cessation Market
    The research report studies the Medications for Smoking Cessation market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
    The global Medications for Smoking Cessation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
    Global Medications for Smoking Cessation Scope and Segment
    The global Medications for Smoking Cessation market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Medications for Smoking Cessation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
    by Type, the market is primarily split into
    Non Nicotine Drugs
    Nicotine Replacement Therapy (NRT)
    by Application, this report covers the following segments
    Hospital Pharmacies
    Retailer Pharmacies
    Online Pharmacies
    Global Medications for Smoking Cessation market: regional analysis, the major regions covered in the report are:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa
    The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
    The Medications for Smoking Cessation key players in this market include:
    Nicotek
    Cipla
    GlaxoSmithKline
    Dr Reddy's Laboratories
    Johnson & Johnson
    Fontem Ventures
    Pfizer
    NovartisNjoy Inc
    Perrigo and Reynolds American Inc.
    Buy now